Aehr Test Systems (AEHR)

$17.88

+0.22

(+1.25%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $17.24
    $18.47
    $17.88
    downward going graph

    3.58%

    Downside

    Day's Volatility :6.66%

    Upside

    3.19%

    downward going graph
  • $9.83
    $54.10
    $17.88
    downward going graph

    45.02%

    Downside

    52 Weeks Volatility :81.83%

    Upside

    66.95%

    downward going graph

Returns

PeriodAehr Test SystemsSector (Technology)Index (Russel 2000)
3 Months
53.97%
6.9%
0.0%
6 Months
12.06%
5.9%
0.0%
1 Year
-65.6%
21.3%
0.0%
3 Years
237.67%
38.3%
-20.2%

Highlights

Market Capitalization
494.1M
Book Value
$3.85
Earnings Per Share (EPS)
1.12
PE Ratio
15.21
PEG Ratio
5.92
Wall Street Target Price
25.0
Profit Margin
50.07%
Operating Margin TTM
15.96%
Return On Assets TTM
5.76%
Return On Equity TTM
35.42%
Revenue TTM
66.2M
Revenue Per Share TTM
2.3
Quarterly Revenue Growth YOY
-25.5%
Gross Profit TTM
23.7M
EBITDA
11.1M
Diluted Eps TTM
1.12
Quarterly Earnings Growth YOY
2.88
EPS Estimate Current Year
0.47
EPS Estimate Next Year
0.3
EPS Estimate Current Quarter
-0.03
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Hold
    0
    0%Buy
    57%Hold
    42%Sell
Based on 7 Wall street analysts offering stock ratings for Aehr Test Systems(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
6
7
Hold
4
2
1
Sell
3
00
00

Analyst Forecast

What analysts predicted

Upside of 39.82%

Current $17.88
Target $25.00

Company Financials

FY18Y/Y Change
Revenue
29.6M
↑ 56.39%
Net Income
528.0K
↓ 109.34%
Net Profit Margin
1.79%
↑ 31.7%
FY19Y/Y Change
Revenue
21.1M
↓ 28.76%
Net Income
-5.2M
↓ 1091.48%
Net Profit Margin
-24.86%
↓ 26.65%
FY20Y/Y Change
Revenue
22.3M
↑ 5.87%
Net Income
-2.8M
↓ 46.48%
Net Profit Margin
-12.57%
↑ 12.29%
FY21Y/Y Change
Revenue
16.6M
↓ 25.53%
Net Income
-2.0M
↓ 27.66%
Net Profit Margin
-12.21%
↑ 0.36%
FY22Y/Y Change
Revenue
50.8M
↑ 206.2%
Net Income
9.5M
↓ 566.21%
Net Profit Margin
18.59%
↑ 30.8%
FY23Y/Y Change
Revenue
65.0M
↑ 27.8%
Net Income
14.6M
↑ 54.04%
Net Profit Margin
22.41%
↑ 3.82%
Q4 FY22Q/Q Change
Revenue
14.8M
↑ 38.83%
Net Income
3.7M
↑ 532.43%
Net Profit Margin
25.14%
↑ 19.62%
Q1 FY23Q/Q Change
Revenue
17.2M
↑ 16.14%
Net Income
4.1M
↑ 10.93%
Net Profit Margin
24.01%
↓ 1.13%
Q2 FY23Q/Q Change
Revenue
22.3M
↑ 29.43%
Net Income
6.1M
↑ 47.89%
Net Profit Margin
27.44%
↑ 3.43%
Q3 FY23Q/Q Change
Revenue
20.6M
↓ 7.39%
Net Income
4.7M
↓ 23.51%
Net Profit Margin
22.66%
↓ 4.78%
Q4 FY23Q/Q Change
Revenue
21.4M
↑ 3.91%
Net Income
6.1M
↑ 30.27%
Net Profit Margin
28.41%
↑ 5.75%
Q1 FY24Q/Q Change
Revenue
7.6M
↓ 64.71%
Net Income
-1.5M
↓ 124.16%
Net Profit Margin
-19.45%
↓ 47.86%
FY18Y/Y Change
Total Assets
31.0M
↑ 0.2%
Total Liabilities
11.7M
↓ 17.22%
FY19Y/Y Change
Total Assets
21.3M
↓ 31.17%
Total Liabilities
5.9M
↓ 49.84%
FY20Y/Y Change
Total Assets
20.6M
↓ 3.44%
Total Liabilities
6.5M
↑ 11.34%
FY21Y/Y Change
Total Assets
21.7M
↑ 5.3%
Total Liabilities
10.2M
↑ 56.74%
FY22Y/Y Change
Total Assets
62.3M
↑ 187.69%
Total Liabilities
11.3M
↑ 10.99%
FY23Y/Y Change
Total Assets
98.1M
↑ 57.46%
Total Liabilities
22.5M
↑ 98.81%
Q1 FY23Q/Q Change
Total Assets
84.4M
↑ 24.95%
Total Liabilities
15.8M
↑ 44.92%
Q2 FY23Q/Q Change
Total Assets
98.1M
↑ 16.29%
Total Liabilities
22.5M
↑ 43.02%
Q3 FY23Q/Q Change
Total Assets
105.5M
↑ 7.46%
Total Liabilities
25.3M
↑ 12.34%
Q4 FY23Q/Q Change
Total Assets
101.2M
↓ 4.07%
Total Liabilities
14.0M
↓ 44.63%
Q1 FY24Q/Q Change
Total Assets
101.6M
↑ 0.42%
Total Liabilities
15.1M
↑ 7.69%
Q2 FY24Q/Q Change
Total Assets
127.9M
↑ 25.9%
Total Liabilities
16.3M
↑ 8.08%
FY18Y/Y Change
Operating Cash Flow
-1.4M
↓ 69.94%
Investing Cash Flow
-572.0K
↑ 19.92%
Financing Cash Flow
925.0K
↓ 95.76%
FY19Y/Y Change
Operating Cash Flow
-5.6M
↑ 317.25%
Investing Cash Flow
-173.0K
↓ 69.76%
Financing Cash Flow
-5.6M
↓ 700.11%
FY20Y/Y Change
Operating Cash Flow
-2.0M
↓ 64.09%
Investing Cash Flow
-163.0K
↓ 5.78%
Financing Cash Flow
2.2M
↓ 139.13%
FY21Y/Y Change
Operating Cash Flow
-2.7M
↑ 33.45%
Investing Cash Flow
-227.0K
↑ 39.26%
Financing Cash Flow
2.0M
↓ 9.76%
FY22Y/Y Change
Operating Cash Flow
1.5M
↓ 155.83%
Investing Cash Flow
-416.0K
↑ 83.26%
Financing Cash Flow
25.8M
↑ 1214.34%
FY23Y/Y Change
Operating Cash Flow
10.0M
↑ 563.86%
Investing Cash Flow
-18.7M
↑ 4384.62%
Financing Cash Flow
7.3M
↓ 71.58%
Q4 FY22Q/Q Change
Operating Cash Flow
-195.0K
↓ 103.57%
Investing Cash Flow
-17.8M
↑ 21032.14%
Financing Cash Flow
620.0K
↓ 185.64%
Q1 FY23Q/Q Change
Operating Cash Flow
-1.1M
↑ 475.9%
Investing Cash Flow
-25.5M
↑ 43.5%
Financing Cash Flow
7.2M
↑ 1068.06%
Q2 FY23Q/Q Change
Operating Cash Flow
5.9M
↓ 622.53%
Investing Cash Flow
-18.7M
↓ 26.76%
Financing Cash Flow
184.0K
↓ 97.46%
Q3 FY23Q/Q Change
Operating Cash Flow
3.9M
↓ 33.52%
Investing Cash Flow
17.7M
↓ 194.96%
Financing Cash Flow
-694.0K
↓ 477.17%

Technicals Summary

Sell

Neutral

Buy

Aehr Test Systems is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aehr Test Systems
Aehr Test Systems
73.65%
12.06%
-65.6%
237.67%
237.67%
Entegris, Inc.
Entegris, Inc.
-7.21%
2.69%
18.44%
4.1%
181.11%
Applied Materials, Inc.
Applied Materials, Inc.
-12.86%
21.22%
45.53%
46.1%
298.74%
Lam Research Corporation
Lam Research Corporation
-16.26%
5.37%
37.63%
38.06%
319.51%
Teradyne Inc.
Teradyne Inc.
-15.34%
17.9%
8.46%
-2.43%
120.65%
Kla-tencor Corporation
Kla-tencor Corporation
-6.21%
27.27%
66.61%
139.4%
447.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aehr Test Systems
Aehr Test Systems
15.21
15.21
5.92
0.47
0.35
0.06
NA
3.85
Entegris, Inc.
Entegris, Inc.
59.67
59.67
1.58
3.29
0.1
0.03
0.0
22.75
Applied Materials, Inc.
Applied Materials, Inc.
23.75
23.75
2.48
8.39
0.45
0.16
0.01
21.98
Lam Research Corporation
Lam Research Corporation
33.44
33.44
3.11
29.71
0.44
0.14
0.01
61.36
Teradyne Inc.
Teradyne Inc.
54.79
54.79
1.34
3.12
0.17
0.09
0.0
16.64
Kla-tencor Corporation
Kla-tencor Corporation
37.29
37.29
2.73
23.28
0.9
0.15
0.01
22.97
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aehr Test Systems
Aehr Test Systems
Hold
$494.1M
237.67%
15.21
50.07%
Entegris, Inc.
Entegris, Inc.
Buy
$18.8B
181.11%
59.67
9.31%
Applied Materials, Inc.
Applied Materials, Inc.
Buy
$171.0B
298.74%
23.75
27.57%
Lam Research Corporation
Lam Research Corporation
Buy
$119.0B
319.51%
33.44
25.35%
Teradyne Inc.
Teradyne Inc.
Buy
$22.4B
120.65%
54.79
16.15%
Kla-tencor Corporation
Kla-tencor Corporation
Buy
$101.8B
447.01%
37.29
27.19%

Insights on Aehr Test Systems

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 21.43M → 7.56M (in $), with an average decrease of 64.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 6.08M → -1.47M (in $), with an average decrease of 124.2% per quarter

  • Vs KLAC

    In the last 1 year, Kla-tencor Corporation has given 66.6% return, outperforming this stock by 132.2%

Institutional Holdings

  • Vanguard Group Inc

    7.25%

  • BlackRock Inc

    7.04%

  • Awm Investment Company Inc

    4.25%

  • Ameriprise Financial Inc

    3.93%

  • BMO Capital Markets Corp.

    3.51%

  • Bank of Montreal

    3.51%

Company Information

headquartered in fremont, california, aehr test systems is a worldwide supplier of systems for burning-in and testing memory and logic integrated circuits and has an installed base of more than 2,500 systems worldwide. aehr test has developed and introduced several innovative products, including the abts, foxtm and max systems and the diepak® carrier. the abts system is aehr test’s newest system for packaged part test during burn-in for both low-power and high-power logic as well as all common types of memory devices. the fox system is a full wafer contact test and burn-in system. the max system can effectively burn-in and functionally test complex devices, such as digital signal processors, microprocessors, microcontrollers and systems-on-a-chip. the diepak carrier is a reusable, temporary package that enables ic manufacturers to perform cost-effective final test and burn-in of bare die.

Organization
Aehr Test Systems
Employees
0
CEO
Mr. Rhea J. Posedel
Industry
Electronic Technology

Discover More

FAQs